TMEM95 Activators

Forskolin increases intracellular cAMP, which in turn activates protein kinase A (PKA). PKA is a pivotal signaling molecule that can phosphorylate a wide array of proteins, potentially including those in the TMEM95-related pathways. IBMX works to elevate cAMP levels by inhibiting the action of phosphodiesterases, thereby sustaining PKA activity. PMA activates protein kinase C (PKC), which phosphorylates serine and threonine residues on various proteins, potentially influencing the TMEM95 complex. In contrast, Okadaic Acid, a potent inhibitor of protein phosphatases 1 and 2A, and Staurosporine, a broad-spectrum kinase inhibitor, manipulate the phosphorylation balance within cells, affecting proteins that may regulate TMEM95 activity.

U73122, by inhibiting phospholipase C, disrupts downstream calcium signaling pathways, which play a crucial role in regulating numerous proteins and cellular processes that could alter TMEM95 function. W-7 Hydrochloride and KN-93, by antagonizing calmodulin and inhibiting Ca2+/calmodulin-dependent protein kinase II, respectively, underscore the significance of calcium signaling in modulating protein function, including the activity of TMEM95. Genistein, a tyrosine kinase inhibitor, may affect TMEM95 by altering phosphorylation cascades, while LY294002 and PD98059, which inhibit phosphatidylinositol 3-kinase and MEK1/2, respectively, target pathways crucial for cell survival and differentiation that might intersect with TMEM95 signaling. Gö 6983, another PKC inhibitor, demonstrates the intricate regulation of phosphorylation states within the cell, which can have a cascading effect on proteins associated with TMEM95.